Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors

被引:18
|
作者
Fléchon, A
Rivoire, M
Biron, P
Droz, JP
机构
[1] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
[2] Ctr Leon Berard, Dept Surg, F-69373 Lyon, France
来源
JOURNAL OF UROLOGY | 2001年 / 165卷 / 06期
关键词
germinoma; testes; mediastinum; drug therapy; salvage therapy;
D O I
10.1016/S0022-5347(05)66243-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The survival of patients with germ cell cancer after failed high dose chemotherapy is poor. We retrospectively reviewed the various treatment choices in this situation. Materials and Methods: From March 1986 to July 1996, 32 patients had disease progression after high dose cisplatin based chemotherapy plus hematopoietic stem cell support. Patients received high dose chemotherapy in the first line (11) or salvage (21) setting. Results: There was relapse after a complete or partial marker negative response after high dose chemotherapy in 19 cases at a median time to disease progression of 7 months (range 1.5 to 72). Salvage treatment involved chemotherapy alone in 5 cases, chemotherapy plus surgery in 6, surgery plus radiotherapy in 3, surgery alone in 2, combined radiotherapy, chemotherapy and surgery in 1, and no treatment in 1 due to a rapid disease course. The most common chemotherapy regimen was combined vinorelbine, ifosfamide and epirubicin. Eight patients achieved a complete response with the resection of all residual disease. At long-term followup 2 patients have been continuously disease-free for 84 and 109 months, respectively. After high dose chemotherapy 13 patients had evidence of disease, including 4 with a partial marker positive response and 9 with progressive disease. Salvage treatment involved chemotherapy plus surgery in 6 cases, chemotherapy alone in 2, no treatment in 2, and radiotherapy plus chemotherapy, radiotherapy alone and surgery alone in 1 each. One patient with progressive disease and 3 with a partial marker positive response achieved a complete response after salvage surgery, and combined surgery and high dose chemotherapy, respectively. These 4 patients have been continuously free of disease for 105, 95, 92 and 72 months, respectively. Conclusions: Six of the 32 patients with relapse or progressive disease after high dose chemotherapy have been free of disease in the long term. The most effective treatment was the resection of all residual masses. Chemotherapy had only marginal activity and the efficacy of radiotherapy seems to have been nil.
引用
收藏
页码:1920 / 1926
页数:7
相关论文
共 50 条
  • [41] Intensive chemotherapy as salvage treatment for solid tumors: focus on germ cell cancer
    Selle, F.
    Gligorov, J.
    Richard, S.
    Khalil, A.
    Alexandre, I.
    Avenin, D.
    Provent, S.
    Soares, D. G.
    Lotz, J. P.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2015, 48 (01) : 13 - 24
  • [42] Implementing Indiana regimen salvage high-dose chemotherapy in relapsed germ cell tumors in Slovakia.
    Chovanec, Michal
    Rusinakova, Zuzana
    Ladicka, Miriam
    Obertova, Jana
    Palacka, Patrik
    Rejlekova, Katarina
    Sycova-Mila, Zuzana
    Orszaghova, Zuzana
    Lesko, Peter
    Mardiak, Jozef
    Vranovsky, Andrej
    Mego, Michal
    Drgona, Lubos
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [43] High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
    Lorch, A.
    Neubauer, A.
    Hackenthal, M.
    Dieing, A.
    Hartmann, J. T.
    Rick, O.
    Bokemeyer, C.
    Beyer, J.
    ANNALS OF ONCOLOGY, 2010, 21 (04) : 820 - 825
  • [44] High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how
    Anja Lorch
    Jörg Beyer
    World Journal of Urology, 2017, 35 : 1177 - 1184
  • [45] High-dose salvage chemotherapy. Germ-cell tumor treatment results in Germany
    Rick, O
    Siegert, W
    Beyer, J
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (06) : 839 - 840
  • [46] High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how
    Lorch, Anja
    Beyer, Jorg
    WORLD JOURNAL OF UROLOGY, 2017, 35 (08) : 1177 - 1184
  • [47] Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant
    Einhorn, Lawrence H.
    Brames, Mary J.
    Juliar, Beth
    Williams, Stephen D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 513 - 516
  • [48] Salvage treatment for germ cell cancer after failed high-dose therapy - response
    Pont, J
    Bokemeyer, C
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 788 - 788
  • [49] SURGERY AFTER HIGH DOSE CHEMOTHERAPY FOR POOR RISK NON SEMINOMATOUS GERM CELL TUMORS (GCTs): A LONG FOLLOW UP
    Morelli, F.
    Cisternino, A.
    Capotorto, A. M.
    Palomba, G.
    Setola, P.
    Maiello, E.
    CANCER TREATMENT REVIEWS, 2010, 36 : S97 - S97
  • [50] The role of high-dose chemotherapy in the management of germ cell tumors
    Bastos, Diogo A.
    Feldman, Darren R.
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (03) : 284 - 293